⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

October 4, 2024

Table 2 from Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy

Elisabeth I. Heath Gregory Dyson Jennifer R. Ribeiro Joanne Xiu Kelsey Poorman Hirva Mamdani Mohammed Najeeb Al Hallak Anthony F. Shields Jailan A. Elayoubi Ira Winer Frank C. Cackowski Gary A. Puckrein Gilberto Lopes Nathaniel Jones Ralph J. Hauke Samuel A. Kareff Milan Radovich George W. Sledge David Spetzler Gregory A. Vidal John L. Marshall

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

COXPH model for all patients in the cohort

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Heath et al. (2024) studied this question.

synapsesocial.com/papers/68e55da7e2b3180350efac25 https://doi.org/10.1158/2767-9764.27169550

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Table 1 from Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy2024
2Supplementary Figure S2 from Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy2024
3Figure 1 from Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy2024
4Supplementary Figure S6 from Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy2024
5Supplementary Figure S1 from Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy2024